| 000 | 01916 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517083124.0 | ||
| 264 | 0 | _c20180116 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1557-3265 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-15-1698 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWarner, Kristy A | |
| 245 | 0 | 0 |
_aTargeting MDM2 for Treatment of Adenoid Cystic Carcinoma. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _c07 2016 |
||
| 300 |
_a3550-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCarcinoma, Adenoid Cystic _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aG1 Phase _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-mdm2 _xmetabolism |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 700 | 1 | _aNör, Felipe | |
| 700 | 1 | _aAcasigua, Gerson A | |
| 700 | 1 | _aMartins, Manoela D | |
| 700 | 1 | _aZhang, Zhaocheng | |
| 700 | 1 | _aMcLean, Scott A | |
| 700 | 1 | _aSpector, Matthew E | |
| 700 | 1 | _aChepeha, Douglas B | |
| 700 | 1 | _aHelman, Joseph | |
| 700 | 1 | _aWick, Michael J | |
| 700 | 1 | _aMoskaluk, Christopher A | |
| 700 | 1 | _aCastilho, Rogerio M | |
| 700 | 1 | _aPearson, Alexander T | |
| 700 | 1 | _aWang, Shaomeng | |
| 700 | 1 | _aNör, Jacques E | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 22 _gno. 14 _gp. 3550-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-15-1698 _zAvailable from publisher's website |
| 999 |
_c25790470 _d25790470 |
||